Astec LifeSciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 1, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	17,556	12,046	13,243	20,932	27,154	34,391
Market Cap Growth	29.47%	-9.04%	-36.73%	-22.91%	-21.04%	74.99%
Enterprise Value	21,926	15,622	18,229	25,222	29,616	36,253
Last Close Price	787.75	539.40	669.91	1054.36	1370.87	1736.51
PE Ratio	-	-	-	-	106.22	38.27
PS Ratio	3.92	2.69	3.47	4.56	4.32	5.08
PB Ratio	4.49	3.08	5.64	5.67	6.47	8.67
P/TBV Ratio	4.80	3.29	6.27	5.98	6.73	8.93
P/OCF Ratio	-	-	-	204.79	36.37	145.70
EV/Sales Ratio	4.89	3.49	4.78	5.50	4.71	5.36
EV/EBITDA Ratio	-	-	-	-	39.00	23.60
EV/EBIT Ratio	-	-	-	-	68.15	30.13
Debt / Equity Ratio	1.15	1.15	2.36	1.34	0.81	0.70
Debt / EBITDA Ratio	-	-	-	-	4.47	1.81
Net Debt / Equity Ratio	1.12	1.12	2.36	1.34	0.81	0.70
Net Debt / EBITDA Ratio	-96.48	-96.48	-8.27	-80.19	4.49	1.82
Net Debt / FCF Ratio	-5.06	-5.06	-18.33	-3.94	-8.00	-3.47
Asset Turnover	0.49	0.49	0.41	0.47	0.67	0.86
Inventory Turnover	2.00	2.00	1.72	1.32	1.69	2.68
Quick Ratio	0.52	0.52	0.41	0.43	0.30	0.57
Current Ratio	0.89	0.89	0.93	1.00	0.95	1.05
Return on Equity (ROE)	-25.84%	-25.84%	-44.57%	-11.88%	6.27%	25.46%
Return on Assets (ROA)	-3.39%	-3.39%	-7.40%	-2.66%	2.90%	9.55%
Return on Invested Capital (ROIC)	-6.18%	-6.12%	-13.31%	-5.13%	4.43%	15.24%
Return on Capital Employed (ROCE)	-11.20%	-11.20%	-21.30%	-7.20%	9.60%	29.60%
Earnings Yield	-4.61%	-6.72%	-10.18%	-2.24%	0.94%	2.61%
FCF Yield	-4.91%	-7.16%	-2.28%	-5.99%	-1.57%	-2.34%
Dividend Yield	-	-	-	0.14%	0.11%	0.09%
Payout Ratio	-	-	-	-	11.50%	3.27%
Buyback Yield / Dilution	-9.18%	-9.18%	-0.01%	-0.02%	-0.04%	-0.05%
Total Shareholder Return	-9.18%	-9.18%	-0.01%	0.13%	0.07%	0.04%